{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:51:54Z","timestamp":1791921114401,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11655-016-2650-7","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T07:46:49Z","timestamp":1482997609000},"page":"496-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial"],"prefix":"10.1007","volume":"23","author":[{"given":"Min","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-dong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-hong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"key":"2650_CR1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/acr.21900","volume":"65","author":"JK Eriksson","year":"2012","unstructured":"Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of rheumatoid arthritis in Sweden\u2014a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken) 2012;65:870\u2013878.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2650_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2009.12.009","volume":"35","author":"GJ Tobon","year":"2010","unstructured":"Tobon GJ, Youinou P, Saraux A. The environment, geoepidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010;35:10\u201314.","journal-title":"J Autoimmun"},{"key":"2650_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/acr.22160","volume":"66","author":"C Xu","year":"2013","unstructured":"Xu C, Wang X, Mu R, Yang L, Zhang Y, Han S, et al. Societal costs of rheumatoid arthritis in China: a hospital-based crosssectional study. Arthritis Care Res (Hoboken) 2013;66:523\u2013531.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2650_CR4","doi-asserted-by":"crossref","first-page":"20406","DOI":"10.7189\/jogh.02.020406","volume":"2","author":"B Dowman","year":"2012","unstructured":"Dowman B, Campbell RM, Zgaga L, Adeloye D, Chan KY. Estimating the burden of rheumatoid arthritis in Africa: a systematic analysis. J Glob Health 2012;2:20406.","journal-title":"J Glob Health"},{"key":"2650_CR5","first-page":"18","volume":"31","author":"JE Tarride","year":"2013","unstructured":"Tarride JE, Haq M, Nakhai-Pour HR, O'Reilly DJ, Xie F, Dolovich L, et al. The excess burden of rheumatoid arthritis in Ontario, Canada. Clin Exp Rheumatol 2013;31:18\u201324.","journal-title":"Clin Exp Rheumatol"},{"key":"2650_CR6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jep.2009.11.010","volume":"127","author":"M Yang","year":"2010","unstructured":"Yang M, Xiao CH, Wu QF, Niu MC, Yao Q, Li KQ, et al. Anti-inflammatory effect of Sanshuibaihu Decoction may be associated with nuclear factor-kappa B and p38 MAPK alpha in collagen-induced arthritis in rat. J Ethnopharmacol 2010;127:264\u2013273.","journal-title":"J Ethnopharmacol"},{"key":"2650_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/ard.2007.080127","volume":"68","author":"PC Verschueren","year":"2009","unstructured":"Verschueren PC, Lories RJ, Daans M, Theate I, Durez P, Westhovens R, et al. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 2009;68:117\u2013123.","journal-title":"Ann Rheum Dis"},{"key":"2650_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00296-010-1370-0","volume":"30","author":"P Zhang","year":"2010","unstructured":"Zhang P, Li J, Han Y, Yu XW, Qin L. Traditional Chinese medicine in the treatment of rheumatoid arthritis: a general review. Rheumatol Int 2010;30:713\u2013718.","journal-title":"Rheumatol Int"},{"key":"2650_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","volume":"668","author":"L Shakir","year":"2011","unstructured":"Shakir L, Hussain M, Javeed A, Ashraf M, Riaz A. Artemisinins and immune system. Eur J Pharmacol 2011;668:6\u201314.","journal-title":"Eur J Pharmacol"},{"key":"2650_CR10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/bjp.2008.11","volume":"153","author":"JX Wang","year":"2008","unstructured":"Wang JX, Tang W, Zhou R, Wan J, Shi LP, Zhang Y, et al. The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses. Br J Pharmacol 2008;153:1303\u20131310.","journal-title":"Br J Pharmacol"},{"key":"2650_CR11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/08923970500418786","volume":"27","author":"S Cuzzocrea","year":"2005","unstructured":"Cuzzocrea S, Saadat F, Di Paola R, Mirshafiey A. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol Immunotoxicol 2005;27:615\u2013630.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2650_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(03)00905-0","volume":"552","author":"E Aldieri","year":"2003","unstructured":"Aldieri E, Atragene D, Bergandi L, Riganti C, Costamagna C, Bosia A, et al. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-\u03baB activation. FEBS Lett 2003;552:141\u2013144.","journal-title":"FEBS Lett"},{"key":"2650_CR13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/aps.2009.138","volume":"30","author":"JX Wang","year":"2009","unstructured":"Wang JX, Hou LF, Yang Y, Tang W, Li Y, Zuo JP. SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages. Acta Pharmacol Sin 2009;30:1428\u20131435.","journal-title":"Acta Pharmacol Sin"},{"key":"2650_CR14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.niox.2008.04.008","volume":"19","author":"VB Konkimalla","year":"2008","unstructured":"Konkimalla VB, Blunder M, Korn B, Soomro SA, Jansen H, Chang W, et al. Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide 2008;19:184\u2013191.","journal-title":"Nitric Oxide"},{"key":"2650_CR15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.intimp.2009.12.006","volume":"10","author":"B Li","year":"2010","unstructured":"Li B, Li J, Pan X, Ding G, Cao H, Jiang W, et al. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation. Int Immunopharmacol 2010;10:344\u2013350.","journal-title":"Int Immunopharmacol"},{"key":"2650_CR16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","volume":"46","author":"H Xu","year":"2007","unstructured":"Xu H, He Y, Yang X, Liang L, Zhan Z, Ye Y, et al. Antimalarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology (Oxford) 2007;46:920\u2013926.","journal-title":"Rheumatology (Oxford)"},{"key":"2650_CR17","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.intimp.2009.09.003","volume":"9","author":"LF Hou","year":"2009","unstructured":"Hou LF, He SJ, Wang JX, Yang Y, Zhu FH, Zhou Y, et al. SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo. Int Immunopharmacol 2009;9:1509\u20131517.","journal-title":"Int Immunopharmacol"},{"key":"2650_CR18","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1462-5822.2010.01508.x","volume":"12","author":"M Prato","year":"2010","unstructured":"Prato M, Gallo V, Giribaldi G, Aldieri E, Arese P. Role of the NFkappaB transcription pathway in the haemozoin-and 15-HETEmediated activation of matrix metalloproteinase-9 in human adherent monocytes. Cell Microbiol 2010;12:1780\u20131791.","journal-title":"Cell Microbiol"},{"key":"2650_CR19","doi-asserted-by":"crossref","first-page":"35125","DOI":"10.1371\/journal.pone.0035125","volume":"7","author":"C Zhu","year":"2012","unstructured":"Zhu C, Xiong Z, Chen X, Peng F, Hu X, Chen Y, et al. Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-kappaB pathway in microglia cells. PLoS One 2012;7:e35125.","journal-title":"PLoS One"},{"key":"2650_CR20","first-page":"645","volume":"27","author":"XJ Cui","year":"2007","unstructured":"Cui XJ, Wang YY, Hou XQ, Pan L, Fu JX. Clinical observation of artesunate in treating rheumatoid arthritis. Chin J Hospit Pharm (Chin) 2007;27:645\u2013647.","journal-title":"Chin J Hospit Pharm (Chin)"},{"key":"2650_CR21","first-page":"457","volume":"37","author":"S Wei","year":"2008","unstructured":"Wei S, Xu GG. Clinical observation of artesunate in treating rheumatoid arthritis. Shanxi Med J (Chin) 2008;37:457\u2013458.","journal-title":"Shanxi Med J (Chin)"},{"key":"2650_CR22","first-page":"155","volume":"17","author":"WH Gu","year":"2011","unstructured":"Gu WH. Clinical trial of the combined effect of Artemisia annua and methotrexate in treating rheumatoid arthritis. Contempor Med (Chin) 2011;17:155\u2013156.","journal-title":"Contempor Med (Chin)"},{"key":"2650_CR23","first-page":"24","volume":"3","author":"R Zhou","year":"2011","unstructured":"Zhou R. Clinical observation on treating rheumatoid arthritis with Artemisia annua plus methotrexate. Clin J Chin Med (Chin) 2011;3:24.","journal-title":"Clin J Chin Med (Chin)"},{"key":"2650_CR24","first-page":"3","volume":"20","author":"Y Li","year":"2011","unstructured":"Li Y, Zhou JG, Yu XJ, Hu JP, Wu TT. Clinical study on rheumatoid arthritis treated with Abrotani Herba and methotrexat. China Pharmaceut (Chin) 2011;20:3\u20134.","journal-title":"China Pharmaceut (Chin)"},{"issue":"6","key":"2650_CR25","first-page":"5","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford) 2012;51(Suppl 6):vi5\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"2650_CR26","first-page":"947","volume":"30","author":"KM Son","year":"2012","unstructured":"Son KM, Song SH, Lim SK, Seo YI, Kim HA. Characteristics of patients with rheumatoid arthritis in clinical remission: the many aspects of DAS28 remission. Clin Exp Rheumatol 2012;30:947\u2013950.","journal-title":"Clin Exp Rheumatol"},{"issue":"43","key":"2650_CR27","first-page":"S14","volume":"24","author":"VK Ranganath","year":"2006","unstructured":"Ranganath VK, Khanna D, Paulus HE. ACR remission criteria and response criteria. Clin Exp Rheumatol 2006;24(Suppl 43):S14\u2013S21.","journal-title":"Clin Exp Rheumatol"},{"key":"2650_CR28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheumatc Diss 2010;69:964\u2013975.","journal-title":"Ann Rheumatc Diss"},{"key":"2650_CR29","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/ard.2008.105577","volume":"69","author":"R O'Mahony","year":"2010","unstructured":"O'Mahony R, Richards A, Deighton C, Scott D. Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2010;69:1823\u20131826.","journal-title":"Ann Rheum Dis"},{"key":"2650_CR30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/NOR.0b013e3181e5c2c9","volume":"29","author":"E Salt","year":"2010","unstructured":"Salt E, Frazier SK. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature. Orthopaed Nurs 2010;29:260\u2013275.","journal-title":"Orthopaed Nurs"},{"key":"2650_CR31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2217\/pgs.13.22","volume":"14","author":"M Umicevic Mirkov","year":"2013","unstructured":"Umicevic Mirkov M, Coenen MJ. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Pharmacogenomics 2013;14:425\u2013444.","journal-title":"Pharmacogenomics"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-016-2650-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-016-2650-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-016-2650-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T05:15:34Z","timestamp":1497590134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-016-2650-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2650"],"URL":"https:\/\/doi.org\/10.1007\/s11655-016-2650-7","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}